| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 298.421 | 328.202 | 312.589 |
| Total Income - EUR | - | - | - | - | - | 0 | 3 | 298.422 | 328.211 | 312.990 |
| Total Expenses - EUR | - | - | - | - | - | 357 | 1.334 | 223.149 | 260.373 | 235.942 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -357 | -1.331 | 75.273 | 67.838 | 77.048 |
| Net Profit/Loss - EUR | - | - | - | - | - | -357 | -1.331 | 72.288 | 64.476 | 67.379 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Olivmedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 45 | 44 | 1.037 | 2.558 | 2.853 |
| Current Assets | - | - | - | - | - | 714 | 2.019 | 208.927 | 195.752 | 207.207 |
| Inventories | - | - | - | - | - | 615 | 1.958 | 63.508 | 58.590 | 89.927 |
| Receivables | - | - | - | - | - | 0 | 0 | 95.068 | 102.506 | 82.697 |
| Cash | - | - | - | - | - | 99 | 61 | 50.350 | 34.657 | 34.583 |
| Shareholders Funds | - | - | - | - | - | -316 | -1.640 | 70.643 | 138.295 | 135.742 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.075 | 3.704 | 139.321 | 53.838 | 68.649 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 6.178 | 6.143 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Olivmedica S.r.l.